ID   HYEP_RAT                Reviewed;         455 AA.
AC   P07687;
DT   01-APR-1988, integrated into UniProtKB/Swiss-Prot.
DT   01-APR-1988, sequence version 1.
DT   02-OCT-2024, entry version 176.
DE   RecName: Full=Epoxide hydrolase 1 {ECO:0000305};
DE            EC=3.3.2.9 {ECO:0000269|PubMed:9854022};
DE   AltName: Full=Epoxide hydratase;
DE   AltName: Full=Microsomal epoxide hydrolase;
DE            Short=mEH {ECO:0000305};
GN   Name=Ephx1 {ECO:0000312|RGD:2557}; Synonyms=Eph-1;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=3032949; DOI=10.1016/s0021-9258(18)45663-3;
RA   Falany C.N., McQuiddy P., Kasper C.B.;
RT   "Structure and organization of the microsomal xenobiotic epoxide hydrolase
RT   gene.";
RL   J. Biol. Chem. 262:5924-5930(1987).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=3755318; DOI=10.1016/0003-9861(86)90408-x;
RA   Porter T.D., Beck T.W., Kasper C.B.;
RT   "Complementary DNA and amino acid sequence of rat liver microsomal,
RT   xenobiotic epoxide hydrolase.";
RL   Arch. Biochem. Biophys. 248:121-129(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Pituitary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, AND TOPOLOGY.
RX   PubMed=9245728; DOI=10.1006/bbrc.1997.7044;
RA   Holler R., Arand M., Mecky A., Oesch F., Friedberg T., Meckey A.;
RT   "The membrane anchor of microsomal epoxide hydrolase from human, rat, and
RT   rabbit displays an unexpected membrane topology.";
RL   Biochem. Biophys. Res. Commun. 236:754-759(1997).
RN   [5]
RP   FUNCTION, CATALYTIC ACTIVITY, BIOPHYSICOCHEMICAL PROPERTIES, SUBCELLULAR
RP   LOCATION, ACTIVE SITE, AND MUTAGENESIS OF ASP-226; GLU-388; GLU-404;
RP   GLU-410 AND HIS-431.
RX   PubMed=9854022; DOI=10.1042/bj3370037;
RA   Arand M., Mueller F., Mecky A., Hinz W., Urban P., Pompon D., Kellner R.,
RA   Oesch F.;
RT   "Catalytic triad of microsomal epoxide hydrolase: replacement of Glu404
RT   with Asp leads to a strongly increased turnover rate.";
RL   Biochem. J. 337:37-43(1999).
RN   [6]
RP   METHYLATION AT ARG-295, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15047867; DOI=10.1091/mbc.e04-02-0101;
RA   Wu C.C., MacCoss M.J., Mardones G., Finnigan C., Mogelsvang S.,
RA   Yates J.R. III, Howell K.E.;
RT   "Organellar proteomics reveals Golgi arginine dimethylation.";
RL   Mol. Biol. Cell 15:2907-2919(2004).
CC   -!- FUNCTION: Biotransformation enzyme that catalyzes the hydrolysis of
CC       arene and aliphatic epoxides to less reactive and more water soluble
CC       dihydrodiols by the trans addition of water. May play a role in the
CC       metabolism of endogenous lipids such as epoxide-containing fatty acids.
CC       Metabolizes the abundant endocannabinoid 2-arachidonoylglycerol (2-AG)
CC       to free arachidonic acid (AA) and glycerol (By similarity). Binds
CC       20(S)-hydroxycholesterol (20(S)-OHC) (By similarity).
CC       {ECO:0000250|UniProtKB:P07099, ECO:0000250|UniProtKB:Q9D379,
CC       ECO:0000269|PubMed:9854022}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=cis-stilbene oxide + H2O = (1R,2R)-hydrobenzoin;
CC         Xref=Rhea:RHEA:23900, ChEBI:CHEBI:15377, ChEBI:CHEBI:50004,
CC         ChEBI:CHEBI:50014; EC=3.3.2.9; Evidence={ECO:0000269|PubMed:9854022};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:23901;
CC         Evidence={ECO:0000305|PubMed:9854022};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-(4-methoxyphenyl)-N-methyl-N-[(3-methyloxetan-3-
CC         yl)methyl]methanamine + H2O = 2-{[(4-
CC         methoxybenzyl)(methyl)amino]methyl}-2-methylpropane-1,3-diol;
CC         Xref=Rhea:RHEA:55764, ChEBI:CHEBI:15377, ChEBI:CHEBI:139161,
CC         ChEBI:CHEBI:139164; EC=3.3.2.9;
CC         Evidence={ECO:0000269|PubMed:9854022};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=8,9-epoxy-(5Z,11Z,14Z)-eicosatrienoate + H2O = 8,9-dihydroxy-
CC         (5Z,11Z,14Z)-eicosatrienoate; Xref=Rhea:RHEA:44048,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:84025, ChEBI:CHEBI:84032;
CC         Evidence={ECO:0000250|UniProtKB:P07099};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44049;
CC         Evidence={ECO:0000250|UniProtKB:P07099};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=11,12-epoxy-(5Z,8Z,14Z)-eicosatrienoate + H2O = 11,12-
CC         dihydroxy-(5Z,8Z,14Z)-eicosatrienoate; Xref=Rhea:RHEA:44044,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:76625, ChEBI:CHEBI:84031;
CC         Evidence={ECO:0000250|UniProtKB:P07099};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:44045;
CC         Evidence={ECO:0000250|UniProtKB:P07099};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-(5Z,8Z,11Z,14Z-eicosatetraenoyl)-glycerol + H2O =
CC         (5Z,8Z,11Z,14Z)-eicosatetraenoate + glycerol + H(+);
CC         Xref=Rhea:RHEA:26132, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:17754, ChEBI:CHEBI:32395, ChEBI:CHEBI:52392;
CC         Evidence={ECO:0000250|UniProtKB:P07099};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:26133;
CC         Evidence={ECO:0000250|UniProtKB:P07099};
CC   -!- ACTIVITY REGULATION: Inhibited by 10-hydroxystearamide and methoxy-
CC       arachidonyl fluorophosphate. {ECO:0000250|UniProtKB:P07099}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=87.5 uM for styrene 7,8-oxide {ECO:0000269|PubMed:9854022};
CC         KM=6.8 uM for 9,10-epoxystearic acid {ECO:0000269|PubMed:9854022};
CC         Vmax=365 nmol/min/mg enzyme with styrene 7,8-oxide as substrate
CC         {ECO:0000269|PubMed:9854022};
CC         Vmax=10 nmol/min/mg enzyme with 9,10-epoxystearic acid as substrate
CC         {ECO:0000269|PubMed:9854022};
CC   -!- SUBCELLULAR LOCATION: Microsome membrane {ECO:0000269|PubMed:9854022};
CC       Single-pass type III membrane protein {ECO:0000269|PubMed:9245728}.
CC       Endoplasmic reticulum membrane {ECO:0000305}; Single-pass type III
CC       membrane protein {ECO:0000269|PubMed:9245728}.
CC   -!- SIMILARITY: Belongs to the peptidase S33 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M15345; AAA41585.1; -; Genomic_DNA.
DR   EMBL; M15339; AAA41585.1; JOINED; Genomic_DNA.
DR   EMBL; M15340; AAA41585.1; JOINED; Genomic_DNA.
DR   EMBL; M15341; AAA41585.1; JOINED; Genomic_DNA.
DR   EMBL; M15342; AAA41585.1; JOINED; Genomic_DNA.
DR   EMBL; M15343; AAA41585.1; JOINED; Genomic_DNA.
DR   EMBL; M15344; AAA41585.1; JOINED; Genomic_DNA.
DR   EMBL; M26125; AAA42350.1; -; mRNA.
DR   EMBL; BC061568; AAH61568.1; -; mRNA.
DR   PIR; A26732; A26081.
DR   RefSeq; NP_001029262.1; NM_001034090.3.
DR   RefSeq; NP_036976.2; NM_012844.3.
DR   AlphaFoldDB; P07687; -.
DR   SMR; P07687; -.
DR   IntAct; P07687; 3.
DR   STRING; 10116.ENSRNOP00000004780; -.
DR   ChEMBL; CHEMBL2299; -.
DR   ESTHER; ratno-hyep; Epoxide_hydrolase.
DR   MEROPS; S33.971; -.
DR   iPTMnet; P07687; -.
DR   PhosphoSitePlus; P07687; -.
DR   jPOST; P07687; -.
DR   PaxDb; 10116-ENSRNOP00000004780; -.
DR   Ensembl; ENSRNOT00000004780.5; ENSRNOP00000004780.2; ENSRNOG00000003515.7.
DR   Ensembl; ENSRNOT00055021371; ENSRNOP00055017286; ENSRNOG00055012533.
DR   Ensembl; ENSRNOT00060011971; ENSRNOP00060009017; ENSRNOG00060007277.
DR   Ensembl; ENSRNOT00065028582; ENSRNOP00065022636; ENSRNOG00065017103.
DR   GeneID; 25315; -.
DR   KEGG; rno:25315; -.
DR   UCSC; RGD:2557; rat.
DR   AGR; RGD:2557; -.
DR   CTD; 2052; -.
DR   RGD; 2557; Ephx1.
DR   eggNOG; KOG2565; Eukaryota.
DR   GeneTree; ENSGT00390000002210; -.
DR   InParanoid; P07687; -.
DR   OrthoDB; 5472392at2759; -.
DR   PhylomeDB; P07687; -.
DR   TreeFam; TF313813; -.
DR   BRENDA; 3.3.2.9; 5301.
DR   Reactome; R-RNO-211945; Phase I - Functionalization of compounds.
DR   SABIO-RK; P07687; -.
DR   PRO; PR:P07687; -.
DR   Proteomes; UP000002494; Chromosome 13.
DR   Bgee; ENSRNOG00000003515; Expressed in liver and 19 other cell types or tissues.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0033961; F:cis-stilbene-oxide hydrolase activity; IMP:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:RGD.
DR   GO; GO:0004301; F:epoxide hydrolase activity; IDA:RGD.
DR   GO; GO:0008142; F:oxysterol binding; ISS:UniProtKB.
DR   GO; GO:0019369; P:arachidonic acid metabolic process; ISS:UniProtKB.
DR   GO; GO:0009056; P:catabolic process; IEA:UniProtKB-KW.
DR   GO; GO:0071385; P:cellular response to glucocorticoid stimulus; IEP:RGD.
DR   GO; GO:0034312; P:diol biosynthetic process; IDA:RGD.
DR   GO; GO:0097176; P:epoxide metabolic process; IDA:UniProtKB.
DR   GO; GO:0001889; P:liver development; IEP:RGD.
DR   GO; GO:0014070; P:response to organic cyclic compound; ISO:RGD.
DR   GO; GO:0009636; P:response to toxic substance; IEA:UniProtKB-KW.
DR   Gene3D; 3.40.50.1820; alpha/beta hydrolase; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR000639; Epox_hydrolase-like.
DR   InterPro; IPR010497; Epoxide_hydro_N.
DR   InterPro; IPR016292; Epoxide_hydrolase.
DR   PANTHER; PTHR21661:SF78; EPOXIDE HYDROLASE 1; 1.
DR   PANTHER; PTHR21661; EPOXIDE HYDROLASE 1-RELATED; 1.
DR   Pfam; PF06441; EHN; 1.
DR   PIRSF; PIRSF001112; Epoxide_hydrolase; 1.
DR   PRINTS; PR00412; EPOXHYDRLASE.
DR   SUPFAM; SSF53474; alpha/beta-Hydrolases; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Aromatic hydrocarbons catabolism; Detoxification;
KW   Endoplasmic reticulum; Hydrolase; Lipid metabolism; Membrane; Methylation;
KW   Microsome; Reference proteome; Signal-anchor; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..455
FT                   /note="Epoxide hydrolase 1"
FT                   /id="PRO_0000080859"
FT   TRANSMEM        1..21
FT                   /note="Helical; Signal-anchor for type III membrane
FT                   protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        22..455
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305|PubMed:9245728"
FT   ACT_SITE        226
FT                   /note="Nucleophile"
FT                   /evidence="ECO:0000269|PubMed:9854022"
FT   ACT_SITE        374
FT                   /note="Proton donor"
FT                   /evidence="ECO:0000250|UniProtKB:P34913"
FT   ACT_SITE        431
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305|PubMed:9854022"
FT   MOD_RES         295
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000269|PubMed:15047867"
FT   MOD_RES         439
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9D379"
FT   MUTAGEN         226
FT                   /note="D->G,N,S: Loss of catalytic activity and loss of
FT                   covalent substrate binding."
FT                   /evidence="ECO:0000269|PubMed:9854022"
FT   MUTAGEN         388
FT                   /note="E->A: Slight decrease in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:9854022"
FT   MUTAGEN         404
FT                   /note="E->A: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:9854022"
FT   MUTAGEN         404
FT                   /note="E->D: Increases catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:9854022"
FT   MUTAGEN         410
FT                   /note="E->A: Slight decrease in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:9854022"
FT   MUTAGEN         431
FT                   /note="H->Q: Loss of catalytic activity and severe
FT                   reduction in substrate binding."
FT                   /evidence="ECO:0000269|PubMed:9854022"
FT   CONFLICT        348..389
FT                   /note="Missing (in Ref. 1; AAA41585)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   455 AA;  52582 MW;  437A15BBCD6861FA CRC64;
     MWLELVLASL LGFVIYWFVS RDKEETLPLG DGWWGPGSKP SAKEDESIRP FKVETSDEEI
     KDLHQRIDRF RASPPLEGSR FHYGFNSNYM KKVVSYWRNE FDWRKQVEIL NQYPHFKTKI
     EGLDIHFIHV KPPQLPSGRT PKPLLMVHGW PGSFYEFYKI IPLLTDPKSH GLSDEHVFEV
     ICPSIPGYGY SEASSKKGLN SVATARIFYK LMTRLGFQKF YIQGGDWGSL ICTNMAQMVP
     NHVKGLHLNM AFISRSFYTM TPLLGQRFGR FLGYTEKDIE LLYPYKEKVF YSIMRESGYL
     HIQATKPDTV GCALNDSPVG LAAYILEKFS TWTKSEYREL EDGGLERKFS LDDLLVNIMI
     YWTTGTIVSS QRYYKENLGQ GIMVHKHEGM KVFVPTGFSA FPSELLHAPE KWVKVKYPKL
     ISYSYMERGG HFAAFEEPKL LAQDIRKFVS LAELQ
//
